"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
| Descriptor ID |
D015415
|
| MeSH Number(s) |
D23.101
|
| Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 3 | 3 |
| 2004 | 2 | 10 | 12 |
| 2005 | 1 | 3 | 4 |
| 2006 | 1 | 7 | 8 |
| 2007 | 0 | 6 | 6 |
| 2008 | 0 | 5 | 5 |
| 2009 | 0 | 13 | 13 |
| 2010 | 3 | 20 | 23 |
| 2011 | 3 | 13 | 16 |
| 2012 | 3 | 21 | 24 |
| 2013 | 3 | 23 | 26 |
| 2014 | 3 | 22 | 25 |
| 2015 | 3 | 24 | 27 |
| 2016 | 5 | 32 | 37 |
| 2017 | 0 | 38 | 38 |
| 2018 | 8 | 35 | 43 |
| 2019 | 2 | 47 | 49 |
| 2020 | 4 | 42 | 46 |
| 2021 | 1 | 28 | 29 |
| 2022 | 0 | 31 | 31 |
| 2023 | 1 | 14 | 15 |
| 2024 | 4 | 8 | 12 |
| 2025 | 3 | 9 | 12 |
| 2026 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Elevated plasma monounsaturated fatty acids and their associations with disease activity, adiposity and sex in patients with rheumatoid arthritis: a cross-sectional study. RMD Open. 2026 Jun 16; 12(2).
-
A comparison of plasma Tsukushi in adolescents with and without metabolic dysfunction-associated steatotic liver disease. Physiol Rep. 2026 Jun; 14(12):e70988.
-
Exploring Phosphatidylethanol Cutoffs for Self-Reported Unhealthy Alcohol Use: An International Multi-Site Analysis. Alcohol Clin Exp Res (Hoboken). 2026 Jun; 50(6):e70361.
-
Challenges and Innovation for Diagnosing and Treatment of Secondary Progressive Multiple Sclerosis. Int J Mol Sci. 2026 May 19; 27(10).
-
Real-Time Breath Diagnostics: Linking Molecular Pathways, Measurement Technologies, and Clinical Translation. Int J Mol Sci. 2026 May 11; 27(10).
-
Effects of LC n-3 PUFA Supplementation on Muscle Pain, Function, and Damage Markers in Healthy Young to Middle-Aged Adults Following Acute or Chronic Exercise: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2026 Apr 30; 18(9).
-
Muscarinic 3 receptor antibodies in Sj?gren's disease: Evaluating assay variability and detection methods. J Immunol Methods. 2026 Mar; 547:114038.
-
Endotoxin Markers Are Elevated in Adolescents With Obesity With and Without Metabolic Dysfunction-Associated Steatotic Liver Disease. Pediatr Obes. 2026 Feb; 21(2):e70093.
-
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment. Arthritis Care Res (Hoboken). 2026 Apr; 78(4):520-527.
-
Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Sci Med. 2025 Nov 28; 12(2).